Comparison of Therapeutic Effect Between Speech Rehabilitation Program and Speech Therapy in Stroke Patients With Aphasia
Launched by KOREA UNIVERSITY GURO HOSPITAL · Apr 11, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a new speech rehabilitation program compared to traditional speech therapy for patients who have speech difficulties after a stroke. The goal is to see which approach helps patients regain their ability to speak more effectively. Participants will undergo evaluations before and after their treatment to measure their progress.
To be eligible for this study, you need to be an adult over 19 years old who has experienced speech disorders due to a stroke. You should also be able to follow the study procedures and agree to participate by signing a consent form. However, if you have trouble understanding or remembering things due to cognitive decline, you may not be able to take part in this trial. Throughout the study, participants can expect to receive focused speech rehabilitation, and their progress will be monitored using specific assessments. This trial is currently looking for volunteers to help improve speech therapy options for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults over 19 years old
- • Those with speech disorders that occurred after a stroke was diagnosed
- • Those who can follow the clinical study procedures
- • Those who voluntarily signed the consent form
- Exclusion Criteria:
- • Patients who have difficulty to consent to research and participate in speech rehabilitation programs due to cognitive decline
About Korea University Guro Hospital
Korea University Guro Hospital is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge medical technology with a multidisciplinary approach to patient care, ensuring the highest standards of safety and efficacy in research. With a focus on a wide array of therapeutic areas, Korea University Guro Hospital is dedicated to contributing to the global medical community by fostering collaboration and promoting evidence-based practices that enhance patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported